Previous 10 | Next 10 |
2023-07-25 10:18:59 ET Gainers: Bullfrog AI ( BFRG ) +35% . Carmell Therapeutics ( CTCX ) +32% . Kiniksa Pharmaceuticals ( KNSA ) +21% . Galecto ( GLTO ) +18% . Akebia Therapeutics ( AKBA ) +16% . Losers: NeuroOne Med...
2023-07-25 08:22:48 ET NeuroOne Medical Technologies Corporation ( NMTC ) -35% . announces pricing of public offering of common stock . Stoke Therapeutics ( STOK ) -34% announces positive new safety & efficacy data from patients treated with STK-001 in the ...
2023-07-21 07:27:17 ET Bluejay Diagnostics, Inc. ( NASDAQ: BJDX ) on Friday announced that its Board has approved a reverse stock split of its shares of common stock at a ratio of 1-for-20. The Reverse Stock Split will become effective at 12:01 a.m. ET on July 24 Bluejay...
ACTON, Mass., July 21, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today announ...
2023-07-08 11:32:00 ET 3 Tips You Need to Know to Spot Undervalued Penny Stocks The exciting realm of penny stock trading offers immense potential for sizable returns, particularly when investors can successfully spot undervalued opportunities. This process, while requiring a keen eye a...
ACTON, Mass., May 19, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today a...
2023-05-10 14:31:59 ET Bluejay Diagnostics press release ( NASDAQ: BJDX ): Q1 GAAP EPS of -$0.12. For further details see: Bluejay Diagnostics GAAP EPS of -$0.12
ACTON, Mass., May 10, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing rapid tests using whole blood on its Symphony platform to improve patient outcomes in critical care settings, ...
2023-03-20 16:33:59 ET Bluejay Diagnostics press release ( NASDAQ: BJDX ): FY GAAP EPS of -$0.46. Revenue of $0.25M. Cash and cash equivalents on December 31, 2022 were $10.1 million, as compared to $19.0 million on December 31, 2021. The Company has limited its cash b...
ACTON, Mass., March 20, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing rapid tests using whole blood on its Symphony platform to improve patient outcomes in critical care settings...
News, Short Squeeze, Breakout and More Instantly...
Bluejay Diagnostics Inc. Company Name:
BJDX Stock Symbol:
NASDAQ Market:
Bluejay Diagnostics Inc. Website:
Bluejay (NASDAQ: BJDX) , a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, recently announced the closing of a firm commitment underwritten public offering. Expected gross proceeds to the company were approxim...
ACTON, Mass., June 28, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today a...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 30.9% to $0.6 on volume of 558,931,853 shares NVIDIA Corporation (NVDA) fell 1.9% to $123.99 on volume of 249,243,816 shares Assure Holdings Corp. (IONM) rose 82.8% to $0.424 on vol...